CD44 cross-linking promotes Plasmodium falciparum invasion
The ability of Plasmodium falciparum to invade and replicate asexually within human red blood cells (RBCs) is central to its pathogenicity. Invasion involves several host-parasite interactions, yet the required host factors remain underexplored, largely due to the intractability of mature RBCs. The transmembrane protein CD44 was identified as a host factor for P. falciparum invasion through a novel forward genetic screen. Here, we identify an anti-CD44 monoclonal antibody, BRIC 222, that significantly promotes P. falciparum invasion through CD44 cross-linking. CD44 cross-linking induced changes in the phosphorylation of RBC cytoskeletal proteins, consistent with a proposed role for CD44 as a co-receptor during invasion. CD44 cross-linking also altered the RBC membrane, increasing the accessibility of several surface proteins, including the essential invasion receptor Basigin. The parasite ligand Erythrocyte Binding Antigen-175 (EBA-175), which interacts with CD44, enhanced P. falciparum invasion and induced RBC membrane changes similarly to BRIC 222. Moreover, both BRIC 222 and EBA-175 increased binding of the PfRH5/PCRCR invasion complex to Basigin, an interaction known to be essential for invasion. We propose that CD44 cross-linking, potentially by EBA-175, serves to coordinate and enhance ligand-receptor interactions and promote signaling to the host cell cytoskeleton, making RBCs more permissive to P. falciparum invasion.
Authors
- Yann Le Guen (ORCID: https://orcid.org/0000-0001-6649-8364)
- Praveesh Valissery (ORCID: https://orcid.org/0000-0001-7159-2689)
- Elizabeth S. Egan (ORCID: https://orcid.org/0000-0002-2112-7700)
- Alan F. Cowman (ORCID: https://orcid.org/0000-0001-5145-9004)
- Angel K. Kongsomboonvech (ORCID: https://orcid.org/0000-0002-2599-131X)
- S.W. Scally (ORCID: https://orcid.org/0000-0002-4264-7772)
- Niraj H. Tolia (ORCID: https://orcid.org/0000-0002-2689-1337)
- Nichole D. Salinas (ORCID: https://orcid.org/0000-0003-4105-3718)
Institutions
- National Institutes of Health (US)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Chan Zuckerberg Biohub San Francisco (US)
- National Institute of Allergy and Infectious Diseases (US)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-12-07
- DOI
- https://doi.org/10.1038/s41467-025-67030-x
- Citations
- 1
- Primary Topic
- Signaling Pathways in Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.81